We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Therapeutic Delivery – Products

A drug capsule cut in half with drug molecules revealing from inside.
Product News

Halozyme Announces Positive Clinical Data of Its High Volume Auto-Injector

Study met primary endpoint and demonstrated successful subcutaneous administration of a 10 mL biologic co-formulated with ENHANZE® in 30 seconds using Halozyme’s proprietary high-volume auto-injector.
The Linkam MFS.
Product News

Linkam To Present Market-Leading Stages at Ams 2023

Linkam Scientific Instruments showcased its range of temperature and environmental control microscopy stages – the DSC450, THMS600, and MFS – at this year’s Advanced Materials Show (AMS) in Columbus, Ohio.
A close up of someone holding a glass test tube.
Product News

Biovectra Signs Service Agreement With Acuitas Therapeutics for Unique Lipid Nanoparticle (Lnp) Delivery System Used in Manufacturing mRNA-Based Therapies

Partnership between two Canadian life sciences leaders offers a commercial GMP manufacturing solution for Acuitas’ licensed partners developing promising next generation therapies.
A scientist pipetting in a lab.
Product News

Sartorius Forms Partnership With Sparta Biodiscovery on Novel Nanoparticle Analysis Platform

SPARTA technology to accelerate the development, manufacture and quality control of nanoparticles used for gene therapies, vaccines, and cancer drugs.
A scientist pipetting coloured liquid into vials.
Product News

TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration

TherageniX, have been awarded a £995,000 grant from Innovate UK. The funding will support the development of the Company’s gene therapy in a powder, a non-viral gene delivery system to improve tissue regeneration following surgery.
Vaccine vials.
Product News

NIH and Exothera Collaborate To Produce GMP Intranasal Vaccine Against SARS-CoV-2

The National Institutes of Health selected Exothera S.A. therapeutics to develop the manufacturing process for NIH’s intranasal vaccine against SARS-CoV-2.
Next gen sequencing preperation.
Product News

MaxCyte Signs Strategic Platform License With Prime Medicine To Advance Next-Generation Gene Editing Therapies

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), announced the signing of a strategic partnership with Prime Medicine, Inc., a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies.
Genetic Medicines
Compendium

Develop Better LNP-Based Genetic Medicines

This content pack contains a variety of webinar and technical note resources to support you in building better genetic medicine products. Download this content pack to discover optimized methods for impurity and integrity analysis.
Overcoming Lentiviral Development Challenges
Compendium

Overcoming Lentiviral Development Challenges

This content pack contains a variety of webinars, technical notes and a compendium of resources to help you overcome a variety of common lentiviral development challenges. Download this content pack to discover innovative solutions for more comprehensive proteome characterization.
The cytiva logo
Product News

Cytiva Launches System To Enable End-to-End Manufacturing of Lipid Nanoparticle Medicines

Cytiva has launched the NanoAssemblr commercial formulation system, purpose-built for clinical and commercial manufacturing of lipid nanoparticle medicines.
Advertisement